x

Search for:

March 7, 2026

Facebook

Main menu

Skip to content

Home
Research
Members
- Current Members
- Previous Members
Publications
- Publications
- Patents
Our News
Links
Contact Us

Archives

Ph.D. Defense

Jiawei Wang defended her Ph.D. dissertation “Drug -Free Macromolecular Therapeutics as a B Cell Depletion Strategy” on January 26th,...

Group skiing at Alta

Christmas Lunch and Department Party

Thanksgiving trip to southern Utah: Arches, Moab (dinner), Monument Valley, Antelope Canyon, Goosenecks State Park, Bryce Canyon

Group Outing at Easton Archery

Trip to Flaming Gorge

Recent Publications

- Polymer-based Chemo-Immunotherapy Combining Immunogenic Cell Death Induction and PD-L1 Blockade Enhances Antitumor Immunity in Melanoma. J. Li, H. Al Faruque, E. Cortes-Sanchez, M. VanBrocklin, S. Hu-Lieskovan, M. Cina, A. Young, J. Kopeček, J. Yang, J. Controlled Release 114193 (2025) [doi]
- Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma. S. Li, J. Li, H.A. Faruque, P. Shami, B. Knoechel, J. Lohr, D. Sborov, J. Yang, J. Kopeček. Adv. Healthcare Mat. e02156 (2025) [doi]
- CD38-targeted antibody-polymer drug conjugates for enhanced treatment of multiple myeloma. J. Li, S. Li, H.A. Faruque, J. Kopeček, D. Sborov, J. Yang. Biomaterials, 324, 123464 (2026) [doi]
- Two-component T-cell immunotherapy enables antigen pre-targeting to reduce cytokine release without forfeiting efficacy. M.T. Gambles, I. Kendell, J. Li, K. Spaihower, D. Sborov, S. Owen, A. Stark, D. Bearss, J. Yang, J. Kopeček. Nanomedicine: Nanotechnology, Biology and Medicine 67, 102825 (2025) [doi]
- PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer. J. Li, H.A. Al Faruque, S. Li, M. Sima, D. Sborov, S. Hu-Lieskovan, T. Werner, J. Kopeček, J. Yang. J. Controlled Release 382, 113682 (2025) [doi]

Click here for full publication list!

© Kopecek / Yang Lab – University of Utah